BYDUREON

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 632cc961c04469ea
Drug Approval Canada Name: BYDUREON
Product Name: BYDUREON
Status: Cancelled Post Market
Status Date: 2022-04-01
Original Market Date: 2016-02-16
Din: 02448610
Drug Class: Human
Dosage Form: Kit , Powder For Suspension, Sustained-Release
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 68:20.06
Atc Original: A10BJ01 EXENATIDE
Atc Name: a 10 bj 01
Aig Number: 0152872002
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

EXENATIDE

2 MG / DOSE

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

632cc961c04469ea

Type

Standard